Table 2. Risk group stratification using risk score generated from miR-204 and miR-139.
Discovery |
Validation |
|||||||
---|---|---|---|---|---|---|---|---|
Risk groupa | HRb | 95% CI | P-value | Ptrend | HRb | 95% CI | P-value | Ptrend |
Univariable | ||||||||
Low RS | Ref. | Ref. | ||||||
Intermediate RS | 2.69 | 0.87–8.34 | 0.087 | 1.78 | 0.64–4.92 | 0.271 | ||
High RS | 8.00 | 2.60–8.34 | <0.001 | <0.001 | 4.67 | 1.80–12.1 | 0.002 | 0.001 |
Multivariable | ||||||||
Low RS | Ref. | Ref. | ||||||
Intermediate RS | 1.15 | 0.31–4.32 | 0.834 | 2.89 | 0.87–9.57 | 0.082 | ||
High RS | 3.45 | 0.81–14.7 | 0.094 | 0.035 | 6.91 | 1.94–24.6 | 0.003 | 0.003 |
Abbreviations: Low RS= low-risk score consists of high levels of miR-204 and miR-139; Intermediate RS=intermediate-risk score consists of high level of either miR-204 or miR-139; High RS=high-risk score consists of low levels of both miRNAs.
Mulitivariable model 1: adjusted for age, gender, clinical stage, smoking, hypertension, and obesity (BMI<30 vs BMI>=30).